The US Food and Drug Administration (FDA) has put on hold all respiratory syncytial virus (RSV) vaccine trials involving infants (aged under 2 years) or RSV naive children aged 2-5 years, after a ...

Public Employees Retirement System of Ohio purchased a new stake in CureVac (NASDAQ:CVAC – Free Report) in the third quarter, ...

Shocking Data Reveals COVID Vaccinated Face Alarming Death Surge** Emerging data from the UK government has raised serious concerns about the safety of COVID-19 vaccinations. Re ...

This year has been marked by concerning developments in the virus’ spread, including widespread detections in wastewater and ...

The Centers for Disease Control and Prevention called it the first severe case in the U.S., though the risk to most of the ...

Dr. Samuel Olaleken Akinyemi a 30 year old Nigerian oncologist at the Bashkir State Medical University Who helped to Create ...

Swayampakula Ramakanth, an analyst from H.C. Wainwright, maintained the Buy rating on Personalis (PSNL – Research Report). The associated price ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $35 ...

A new type of norovirus is causing a very high number of cases in countries like England, just as a large trial of an mRNA ...

Moderna 's ( MRNA 3.13%) wild success in the COVID-19 vaccine market has worn off. The company's revenue, earnings, and stock ...

Childhood vaccination is a success story. But concerns around vaccines endure. Especially, it seems, among the individuals ...